Value for Money in Ukraine’s HIV Response

Vista sencilla de ítem
dc.creatorWorld Bank Group
dc.date2016-08-02T20:50:32Z
dc.date2016-08-02T20:50:32Z
dc.date2016
dc.date.accessioned2026-07-01T00:48:38Z
dc.descriptionUkraine experiences one of the most severe HIV epidemics in Europe. This policy brief is a result of a team effort involving the State Institution Ukrainian Center for Socially Dangerous Disease Control of the MOH of Ukraine, and international partners. The study was part of the regional initiatives on HIV allocative efficiency analysisi and funded and technically supported by the World Bank and UNAIDS. We greatly acknowledge the contributions of all the team members, stakeholders and other partners. There are major opportunities, but also major risks in relation to HIV investment decisions in Ukraine in the coming five years. While decreasing funding would lead to a marked increase in deaths, new infections and future health care costs, a smart approach to increasing HIV investment, could avert around half of the new infections and deaths up to 2030 compared to business as usual. The keys to success are (1) scaling up ART; (2) reforming procurement to reduce unit costs for drugs and diagnostics; (3) sustaining prevention programs for key populations and further enhancing coverage with strong geographical prioritization; (4) establishing domestic financing and management of community systems for prevention and adherence support; and (5) strengthen integration with other health, social and drug-use treatment programs. Bold and immediate investment in the mentioned key programs and measures to improve efficiency are needed to avoid large increases in future health care cost and, most importantly, prevent over 150,000 new infections and save over 110,000 lives by 2030.
dc.formatapplication/pdf
dc.formattext/plain
dc.identifierhttp://documents.worldbank.org/curated/en/2016/01/26411947/value-money-ukraine’s-hiv-response-strategic-investment-improved-efficiency
dc.identifierhttps://hdl.handle.net/10986/24769
dc.identifier10.1596/24769
dc.identifier.urihttp://hdl.handle.net/123456789/411348
dc.languageEnglish
dc.languageen_US
dc.publisherWorld Bank, Washington, DC
dc.rightsCC BY 3.0 IGO
dc.rightshttp://creativecommons.org/licenses/by/3.0/igo/
dc.rightsWorld Bank
dc.subjectRISKS
dc.subjectTREATMENT
dc.subjectDIAGNOSIS
dc.subjectSEX WORKERS
dc.subjectLOCAL AUTHORITIES
dc.subjectMOTHER-TO-CHILD TRANSMISSION
dc.subjectSEXUAL PARTNERS
dc.subjectDEATHS
dc.subjectPREVENTION
dc.subjectDISEASE BURDEN
dc.subjectDRUG INJECTION
dc.subjectLOCAL GOVERNMENTS
dc.subjectSEXUAL HEALTH
dc.subjectRESOURCE ALLOCATION
dc.subjectHEALTH CARE
dc.subjectDRUGS
dc.subjectDEATH
dc.subjectPREVALENCE
dc.subjectHIV PREVENTION
dc.subjectEFFECTS
dc.subjectHEALTH
dc.subjectTRANSMISSION
dc.subjectEPIDEMIC
dc.subjectVIRUSES
dc.subjectNUMBER OF PEOPLE
dc.subjectPOPULATION SIZE
dc.subjectHEALTH FACILITIES
dc.subjectSEXUAL TRANSMISSION
dc.subjectLIFE EXPECTANCY
dc.subjectHEALTH SECTOR
dc.subjectINSTITUTIONAL MECHANISMS
dc.subjectMINISTRY OF HEALTH
dc.subjectNATIONAL AIDS
dc.subjectAIDS EPIDEMIC
dc.subjectLIFE
dc.subjectPATIENTS
dc.subjectINTERVENTION
dc.subjectGLOBAL CONSENSUS
dc.subjectNEGATIVE EFFECTS
dc.subjectHIV INFECTION
dc.subjectPREVENTION OF MOTHER-TO-CHILD TRANSMISSION
dc.subjectCONDOM USE
dc.subjectTUBERCULOSIS
dc.subjectSCREENING
dc.subjectSERVICE DELIVERY
dc.subjectGLOBAL HEALTH
dc.subjectHIV/AIDS
dc.subjectEPIDEMICS
dc.subjectMORTALITY
dc.subjectALLOCATION OF RESOURCES
dc.subjectCOUNSELLING
dc.subjectHIV TESTING
dc.subjectFEMALE SEX WORKERS
dc.subjectAIDS SPENDING
dc.subjectAIDS DEATHS
dc.subjectDIAGNOSES
dc.subjectMOTHER-TO-CHILD
dc.subjectNEEDLES
dc.subjectWORKERS
dc.subjectNEEDLE SHARING
dc.subjectSOCIAL SERVICES
dc.subjectHIV
dc.subjectTB
dc.subjectSEX WITH MEN
dc.subjectHEALTH OUTCOMES
dc.subjectPREVENTION INTERVENTIONS
dc.subjectREGIONAL INITIATIVES
dc.subjectPOPULATIONS
dc.subjectUNAIDS
dc.subjectDRUG USE
dc.subjectMOTHER
dc.subjectBULLETIN
dc.subjectPOLICY
dc.subjectBURDEN OF DISEASE
dc.subjectPRIMARY HEALTH CARE
dc.subjectREST
dc.subjectTHERAPY
dc.subjectHEPATITIS
dc.subjectDIAGNOSTICS
dc.subjectINTERNET
dc.subjectRISK FACTORS
dc.subjectHEALTH SYSTEM
dc.subjectNEW INFECTIONS
dc.subjectSEX
dc.subjectPOLICY BRIEF
dc.subjectPREGNANT WOMEN
dc.subjectHIV TRANSMISSION
dc.subjectCASUAL SEX
dc.subjectGOVERNMENT AGENCIES
dc.subjectFEMALES
dc.subjectDISEASE
dc.subjectDISEASE CONTROL
dc.subjectGENERIC DRUGS
dc.subjectNATIONAL PLAN
dc.subjectISOLATION
dc.subjectPARTNERS
dc.subjectCONDOM
dc.subjectINFECTION
dc.subjectDISABILITY
dc.subjectINFECTIONS
dc.subjectLIMITED RESOURCES
dc.subjectALL
dc.subjectPOPULATION
dc.subjectVISION
dc.subjectSTRATEGY
dc.subjectMALES
dc.subjectPOPULATION DATA
dc.subjectWOMEN
dc.subjectHIV INFECTIONS
dc.subjectAIDS
dc.subjectFEMALE
dc.subjectIMPLEMENTATION
dc.subjectAIDS PROGRAM
dc.subjectVIRAL LOAD
dc.titleValue for Money in Ukraine’s HIV Response
dc.titleStrategic Investment and Improved Efficiency
dc.typeReport
dc.typeRapport
dc.typeInforme

Archivos

Colecciones

AgroKnow